August 29, 2025

Enhabit, Inc. (EHAB) Stock Analysis: Exploring a Potential 18% Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find Enhabit, Inc. (NASDAQ: EHAB) an intriguing prospect. With its focus on home health and hospice services, Enhabit serves a critical role..

CureVac N.V. (CVAC) Stock Analysis: Navigating the mRNA Frontier with Strategic Developments

CureVac N.V. (NASDAQ: CVAC) is a prominent player in the biotechnology industry, with a focus on developing transformative medicines based on messenger RNA (mRNA) technology. Headquartered in Tübingen, Germany, CureVac..

MeiraGTx Holdings plc (MGTX): Unveiling a Potential 264.93% Upside in Biotechnology

Investors with an eye on the biotechnology sector should pay close attention to MeiraGTx Holdings plc (NASDAQ: MGTX), a clinical-stage gene therapy company that is creating ripples in the healthcare..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 99% Upside Potential in Telehealth Innovation

LifeMD, Inc. (LFMD) is carving a niche in the burgeoning telehealth sector, presenting a compelling opportunity for investors focused on healthcare innovation. Operating in the health information services industry, LifeMD..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a Potential 156.85% Upside in the Biotech Sector

Nuvation Bio Inc. (NASDAQ: NUVB) is making waves in the biotechnology sector with its promising pipeline of oncology-focused therapeutic candidates. Despite its current stock price of $2.92, the company has..

AnaptysBio, Inc. (ANAB) Investor Outlook: Exploring a Potential 126% Upside

AnaptysBio, Inc. (NASDAQ: ANAB) is capturing investor attention with its impressive potential upside of 126.03%, according to recent analyst ratings. As a clinical-stage biotechnology firm, AnaptysBio is strategically positioned in..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring 234% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA) has been capturing the attention of investors in the healthcare sector, particularly within the biotechnology industry. This San Diego-based clinical-stage biopharmaceutical company specializes in developing..

HealthStream, Inc. (HSTM) Stock Analysis: Evaluating a 21.08% Potential Upside in Healthcare SaaS

HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the healthcare information services sector, offers a unique investment opportunity with a potential upside of 21.08%. As a provider of Software-as-a-Service (SaaS)..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a 39% Upside in a Challenging Market

Cross Country Healthcare, Inc. (NASDAQ: CCRN) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $438.03 million, the company..

Castle Biosciences, Inc. (CSTL) Investor Outlook: Unpacking a 51.85% Potential Upside

Castle Biosciences, Inc. (NASDAQ: CSTL), a prominent player in the healthcare sector, specifically in diagnostics and research, is generating buzz among investors with its robust potential upside of 51.85%. Based..

InnovAge Holding Corp. (INNV) Stock Analysis: Evaluating a 30.55% Potential Upside in the Healthcare Sector

InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, specifically within the medical care facilities industry, is currently navigating a complex landscape. With its headquarters in Denver,..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating a Challenging Healthcare Staffing Market

AMN Healthcare Services Inc (AMN), a notable player in the healthcare sector, is grappling with a challenging landscape within the medical care facilities industry. With a market capitalization of $768.4..

Opthea Limited (OPT): Investor Outlook on Potential Downside and Strategic Focus

Opthea Limited (OPT) stands at a pivotal juncture as it navigates the challenging waters of the biotechnology sector. With a market capitalization of approximately $524.82 million, this Australian biopharmaceutical company..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Unpacking the 14.99% Potential Upside

Fulgent Genetics, Inc. (NASDAQ: FLGT), a player in the diagnostics and research industry within the healthcare sector, has captured investor attention with a notable potential upside of 14.99%. With a..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Biotech Terrain with a Cautious Eye

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to cell programming. Headquartered in Boston, Massachusetts, Ginkgo Bioworks..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Report: Analyst Consensus Points to 34% Upside Potential

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is a burgeoning player in the biotechnology sector that is capturing investor attention with its promising pipeline targeting neurodegenerative diseases and rare endocrine conditions. With..

Talkspace, Inc. (TALK) Stock Analysis: Unlocking an 80% Potential Upside in the Virtual Healthcare Arena

For investors with an eye on the burgeoning field of digital health, Talkspace, Inc. (NASDAQ: TALK) presents a compelling opportunity. As a leader in virtual behavioral healthcare, Talkspace connects patients..

Nurix Therapeutics, Inc. (NRIX) Investor Outlook: Evaluating a 217% Potential Upside

Nurix Therapeutics, Inc. (NASDAQ: NRIX), a clinical-stage biopharmaceutical company, is currently making waves in the biotechnology sector with its innovative small molecule and antibody therapies aimed at tackling cancer and..

Beta Bionics, Inc. (BBNX) Stock Analysis: Exploring a 26.49% Potential Upside in the Medical Device Sector

Beta Bionics, Inc. (NASDAQ: BBNX) is capturing the attention of investors with its innovative approach to diabetes care. As a commercial-stage medical device company, Beta Bionics is committed to enhancing..

Search

Funds

August 29, 2025

Search

Funds

August 29, 2025

FTSE 100

Funds